Table 3.
Factor | Univariate Logistic Regression | Multivariate Logistic Regression | ||||
---|---|---|---|---|---|---|
OR | (95% CI) | P Value | OR | (95% CI) | P Value | |
Agea | 1.00 | (.97–1.03) | .994 | |||
Male sex | 1.02 | (.28–3.70) | .979 | |||
CD4 T-cell countb | 0.74 | (.59–.93) | .011 | |||
CD8 T-cell countb | 1.07 | (.99–1.16) | .075 | |||
CD4/CD8 ratioc | 0.75 | (.63–.90) | .002 | 0.75 | (.62–.91) | .003 |
HIV RNAd | 1.46 | (.80–2.69) | .215 | |||
ART duratione | 0.92 | (.88–.97) | .001 | |||
On-ART CD4 T-cell countb | 0.77 | (.62–.95) | .015 | |||
On-ART CD8 T-cell countb | 1.17 | (1.04–1.32) | .011 | |||
On-ART CD4/CD8 ratioc | 0.80 | (.71–.91) | .001 | |||
On-ART IDO activityf | 1.09 | (1.04–1.13) | <.0001 | 1.09 | (1.04–1.14) | <.0001 |
Abbreviations: ART, antiretroviral therapy; CI, confidence interval; HIV, human immunodeficiency virus; IDO, indoleamine 2,3-dioxygenase; OR, odds ratio.
aShown per 1 year increase.
bShown per 100 cells/μL increase.
cShown per 0.1 increase.
dShown per 1 log10 copies/mL increase, data from 99 patients.
eShown per 1 month increase.
fShown per 1 nM/μM increase.